Net Cash Provided by (Used in) Operating Activities |
-3.5K |
USD |
+16.7% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
8.2K |
USD |
+26.2% |
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
3.33M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-3.5K |
USD |
-188% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.82K |
USD |
-70.5% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
106K |
USD |
+6.87% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
106K |
USD |
+6.87% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
714K |
USD |
0% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2023 |
FY 2023 |